NRx Pharmaceuticals

Veja o organograma con seus 12 executivos principais

Biografias mais buscadas da NRx Pharmaceuticals

• Steve Willard, Chief Executive Officer and Director
• Chaim Hurvitz, Director
• Patrick Flynn, Director

Recentes movimentos de executivos em NRx Pharmaceuticals

• Janet Rehnquist, ingressou na Companhia como Director  (Notícia publicada em 27 de dezembro de 2023).

Criar um alerta
para seguir os movimentos de executivos da NRx Pharmaceuticals.

NRx Pharmaceuticals possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).

Popular M&A news in Farmacêutica

• MedMen has filed for bankruptcy protection  (publicado em 28 de abril de 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (publicado em 23 de março de 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (publicado em 19 de março de 2024).

Outros contatos sugeridos na indústria do Farmacêutica

• Jean-Frédéric Paulsen - Executive Chairman of the Board da Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member da Galenika
• Thierry Abribat - Chief Executive Officer da Amolyt Pharma

Saiba mais sobre a indústria do Farmacêutica >

Últimos comunicados de imprensa de NRx Pharmaceuticals

• NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression
• NRx Pharmaceuticals Investors - Press Releases
• NRx Pharmaceuticals Investors - Press Releases
• NRx Pharmaceuticals Investors - Press Releases
• NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
• NRx Pharmaceuticals Investors - Press Releases
• NRx Pharmaceuticals Investors - Press Releases
• NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
• NRx Pharmaceuticals Investors - Press Releases
• NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
• View more press releases Close

Redes sociais sobre NRx Pharmaceuticals

• NRx Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• NRx Pharmaceuticals na LinkedIn, Twitter e YouTube

Contate seus executivos por e-mail agora, incluindo Patrick Flynn

Ligue para a NRx Pharmaceuticals em +1 484...

Veja o organograma

Register to receive your alert

Relatório um erro